G00052MO

Summary
GlyTouCan ID
G00052MO
IUPAC Condensed
Fuc(a1-2)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-
Motifs
Blood group H (type 2) Leb Lewis b Ley
Subsumption Level
Fully-defined saccharide
Monoisotopic Mass
675.26
3D Structures
GlycoShape
G00052MO
Displaying 1 entry
Archetype α β
G04690JX
G82236PZ
G00052MO
Organisms
Taxonomic Hierarchy
GlycoGene Database (GGDB)
Displaying all 2 entries
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Product Reducing terminal(Product) Reference
FUT5 GDP-Fuc
G61459JW
R
G00052MO
R
FUT3 GDP-Fuc
G61459JW
R
G00052MO
R
Displaying all 5 entries
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Product Reducing terminal(Product) Reference
FUT5 GDP-Fuc
G61459JW
R
G00052MO
R
FUT5 GDP-Fuc
G61459JW
(CH2)8COOCH3
G00052MO
(CH2)8COOCH3
FUT3 GDP-Fuc
G61459JW
R
G00052MO
R
FUT3 GDP-Fuc
G61459JW
(CH2)8COOCH3
G00052MO
(CH2)8COOCH3
FUT6 GDP-Fuc
G61459JW
(CH2)8COOCH3
G00052MO
(CH2)8COOCH3
GlycoEpitope
Epitope ID
EP0018
Sequence Descriptors
GlycoCT
RES
1b:b-dglc-HEX-1:5
2s:n-acetyl
3b:a-lgal-HEX-1:5|6:d
4b:b-dgal-HEX-1:5
5b:a-lgal-HEX-1:5|6:d
LIN
1:1d(2+1)2n
2:1o(3+1)3d
3:1o(4+1)4d
4:4o(2+1)5d
WURCS
WURCS=2.0/3,4,3/[a2122h-1b_1-5_2*NCC/3=O][a1221m-1a_1-5][a2112h-1b_1-5]/1-2-3-2/a3-b1_a4-c1_c2-d1
Literature
Displaying entries 171 - 180 of 410 in total
PubMed ID Title First Author Publication Date Source
16484342 Glycosyltransferases involved in type 1 chain and Lewis antigen biosynthesis exhibit glycan and core chain specificity Holgersson J 2006 Feb 16
  • PubChem
16477004 An enzymatic ruler modulates Lewis antigen glycosylation of Helicobacter pylori LPS during persistent infection Nilsson C 2006 Feb 13
  • PubChem
16963623 Inhibition of Xenograft Tumor Growth and Down-Regulation of ErbB Receptors by an Antibody Directed against Lewis Y Antigen Farhan H 2006 Dec
  • PubChem
16595507 Enhanced efficacy of 90Y-radiolabeled anti-Lewis Y humanized monoclonal antibody hu3S193 and paclitaxel combined-modality radioimmunotherapy in a breast cancer model Kelly MP 2006 Apr
  • PubChem
16140965 Improved Effector Functions of a Therapeutic Monoclonal Lewis Y-Specific Antibody by Glycoform Engineering Schuster M 2005 Sep 01
  • PubChem
16266323 Three‐dimensional structures of carbohydrate determinants of Lewis system antigens: Implications for effective antibody targeting of cancer Yuriev E 2005 Oct 21
  • PubChem
16203806 Enhanced efficacy of radioimmunotherapy with 90Y-CHX-A''-DTPA-hu3S193 by inhibition of epidermal growth factor receptor (EGFR) signaling with EGFR tyrosine kinase inhibitor AG1478 Lee FT 2005 Oct 01
  • PubChem
16248790 Carbohydrate Mimotopes in the Rational Design of Cancer Vaccines Pashov A 2005 Oct 01
  • PubChem
16234847 Characterization of murine monoclonal antibodies against Helicobacter pylori lipopolysaccharide specific for Lex and Ley blood group determinants Altman E 2005 Oct
  • BCSDB
  • GlyGen
16155001 DC-SIGN Mediates Binding of Dendritic Cells to Authentic Pseudo-LewisY Glycolipids of Schistosoma mansoni Cercariae, the First Parasite-specific Ligand of DC-SIGN Meyer S 2005 Nov 11
  • PubChem
PubAnnotation
Displaying entries 1 - 5 of 10 in total
Title Authors Source Publication Date PubMed ID
Development of potent monoclonal antibody auristatin conjugates for cancer therapy.
  • Doronina SO
  • Toki BE
  • Torgov MY
  • Mendelsohn BA
  • Cerveny CG
  • Chace DF
  • DeBlanc RL
  • Gearing RP
  • Bovee TD
  • Siegall CB
  • Francisco JA
  • Wahl AF
  • Meyer DL
  • Senter PD
Nat Biotechnol 2003 Jul 12778055
The expression of free oligosaccharides in human seminal plasma.
  • Chalabi S
  • Easton RL
  • Patankar MS
  • Lattanzio FA
  • Morrison JC
  • Panico M
  • Morris HR
  • Dell A
  • Clark GF
J Biol Chem 2002 Sep 6 12063266
Phenotypic variation in molecular mimicry between Helicobacter pylori lipopolysaccharides and human gastric epithelial cell surface glycoforms. Acid-induced phase variation in Lewis(x) and Lewis(y) expression by H. Pylori lipopolysaccharides.
  • Moran AP
  • Knirel YA
  • Senchenkova SN
  • Widmalm G
  • Hynes SO
  • Jansson PE
J Biol Chem 2002 Feb 22 11741906
Pursuit of optimal carbohydrate-based anticancer vaccines: preparation of a multiantigenic unimolecular glycopeptide containing the Tn, MBr1, and Lewis(y) antigens.
  • Allen JR
  • Harris CR
  • Danishefsky SJ
J Am Chem Soc 2001 Mar 7 11456809
The fucosylated histo-blood group antigens H type 2 (blood group O, CD173) and Lewis Y (CD174) are expressed on CD34+ hematopoietic progenitors but absent on mature lymphocytes.
  • Cao Y
  • Merling A
  • Karsten U
  • Schwartz-Albiez R
Glycobiology 2001 Aug 11479278

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.4.0

Last updated: December 8, 2025